Scott Koenig, M.D., Ph.D.

Scott Koenig, M.D., Ph.D.

Former Chief Executive Officer and current DirectoratMacrogenics· In proxies 2022–2025

Pay in FY2025Macrogenics stock -50.5% the same year

Scott Koenig, M.D., Ph.D. was paid $953.0K in FY2025 (Dec). Macrogenics stock fell 50.5% that year.

Pay$100 in the stock at the end of FY21 → $21
Pay is from the Summary Compensation Table of each Macrogenics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. MacrogenicsPublic company · 4 yr
    • Former Chief Executive Officer and current Director2022 – Present · 4 yrStock in role -85%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?